Why the study?
The study was conducted to explore the relationship between the triglyceride-glucose-body mass index and all-cause mortality, and to determine predictive factors for survival in CVD patients.
Does the triglyceride-glucose-body mass index (TyG-BMI) predict all-cause mortality in patients with cardiovascular disease?
Population
1085 CVD patients in the NHANES database from 2007 to 2016
Comparison
Four groups based on weighted quartiles of TyG-BMI
Design
Retrospective database cohort study
Authors
Loading...
TyG-BMI may aid mortality risk stratification in CVD; leaves open incremental value beyond established predictors in prospective validation.
Does the triglyceride-glucose-body mass index (TyG-BMI) predict all-cause mortality in patients with cardiovascular disease?
Higher TyG-BMI index is significantly associated with lower all-cause mortality in patients with cardiovascular disease, suggesting it may serve as a useful prognostic indicator.
Sun et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: